- Home
- Applications
- north america
- in vitro
Refine by
In Vitro Product Applications In North America
13 applications found
Meeting the growing need for higher performing materials for medical devices, in-vitro diagnostics and pharmaceutical packaging. From our experience in multiple industries and consultation with regulatory experts, Ampacet has developed a new portfolio of medical grade masterbatch solutions. ...
ByAmpacet Corporation based in Tarrytown, NEW YORK (USA)
Gene synthesis refers to the artificial synthesis of double-stranded DNA molecules in vitro. At present, the required target DNA fragments are mainly obtained and amplified through gene cloning. ...
ByCD Biosciences - htDNA-chip® based in Shirley, NEW YORK (USA)
A high incidence of thromboembolic complications leading to organ-failure, stroke, pulmonary embolism (PE) and deep vein thrombosis (DVT) have been reported in asymptomatic, symptomatic, and recovering patient groups. ...
ByAbram Scientific, Inc. based in Menlo Park, CALIFORNIA (USA)
BOC Sciences is committed to supplying cost-effective products and services. We provide Hydroxysafflor yellow A (Cas No:78281-02-4). More information, please visit the website: http://www.bocsci.com/hydroxysafflor-yellow-a-cas-78281-02-4-item-474840.html ...
ByBOC Sciences based in Shirley, NEW YORK (USA)
Cyrus’s protein biochemistry capabilities include advanced selection methodologies in both yeast and mammalian cell systems. These tools can interrogate large numbers of mutations in cell surface receptors and many globular proteins, offering a unique path forward for protein optimization based on high quality, physiologically-relevant data in eukaryotic or – specifically – human ...
ByCyrus Biotechnology Inc. based in Seattle, WASHINGTON (USA)
In the era of global information, traditional storage technologies have been slightly tested. DNA must realize reliable information encoding. Only when DNA becomes a viable competitor of traditional storage technology is the first step for DNA to realize information storage. The most important thing is to produce nucleotide strings cheaply and quickly. For DNA, it is composed of four different monomers, consisting of a deoxyribonucleic acid having a skeleton with phosphoric acid. First, DNA is a polymer biological ...
ByCD Biosciences - htDNA-chip® based in Shirley, NEW YORK (USA)
BOC Sciences is committed to supplying cost-effective products and services. We provide Ceftriaxone Sodium (Cas No:74578-69-1). More information, please visit the website: http://www.bocsci.com/ceftriaxone-sodium-cas-74578-69-1-item-97893.html ...
ByBOC Sciences based in Shirley, NEW YORK (USA)
With the development of society, people are becoming more and more concerned about appearance and body type. The medical beauty industry came into being and developed rapidly. The application of DNA technology in the medical beauty industry is becoming more and more common. Firstly, genetic testing related to skin conditions and obesity is more and more popular. According to the test results, the obesity type and skin condition can be known clearly, and the appearance and body shape problems can be solved in a ...
ByCD Biosciences - htDNA-chip® based in Shirley, NEW YORK (USA)
Isolating edited-pluripotent stem cells with traditional sorting techniques can subject the cells to rough conditions in which gene expression, genomic stability and overall cell-health can become compromised. Microfluidic cell sorting with the WOLF, along with single cell deposition using the N1 single cell dispenser, eliminates the challenges that pluripotent stem cells face by sorting at gentle pressures without decompression shock and shear stress, and allow for efficient single cell deposition for high ...
ByNanoCellect Biomedical, Inc. based in San Diego, CALIFORNIA (USA)
Increase clinical translation with Organ-Chips for ADME-Tox assessments. Accurate ADME-Tox profiling of preclinical drug candidates remains a challenge. Preclinical ADME-Tox (Absorption, Distribution, Metabolism, Excretion, and Toxicity) studies are pivotal to predicting human response. However, approximately 30% of drugs fail during human clinical trials due to adverse reactions despite promising preclinical study results, and another 60% fail due to lack of efficacy. As companies broaden the modality toolbox ...
ByEmulate based in Boston, MASSACHUSETTS (USA)
As targeted therapies evolve and the limitations of antibody-based therapies become clearer, a growing number of research teams are exploring the therapeutic potential of ...
ByBase Pair Biotechnologies, Inc. based in Pearland, TEXAS (USA)
In many therapeutic areas, current treatments involve significant side effects. Combining drug compounds with affinity agents that target specific cell surface receptors can dramatically reduce off-target effects and improve treatment effectiveness. In several studies, aptamer-mediated drug delivery has reduced toxicity and improved drug performance. ...
ByBase Pair Biotechnologies, Inc. based in Pearland, TEXAS (USA)
More than 5 million people in the United States and an estimated 50 million people worldwide are living with Alzheimer’s disease. More than 10 million people worldwide are living with Parkinson’s. Brain tumors and tumors of the central nervous system are the most common form of cancer in children under 19 and the leading cause of cancer-related deaths in children under 14 in the U.S. While antibody drugs have made great strides in cancer therapies, crossing the blood-brain barrier (BBB) and ...
ByBase Pair Biotechnologies, Inc. based in Pearland, TEXAS (USA)